The Light for Sight foundation provides ophthalmologists around the world with CXL training and ensures that no young patient must go without treatment

Implanting a toric IOL during cataract surgery is great way of dealing with a patient’s corneal astigmatism – but off-axis rotation of the IOL can erode those benefits.

More than 400 participants from 49 countries accepted an invitation from the Heidelberg Engineering Academy to the 13th International SPECTRALIS Symposium (ISS) in Valencia, Spain, held on October 16 and 17, 2015. This success was certainly partly due to the attractive venue, but above all, it can be attributed to the high-level international faculty, the interesting scientific program, and the constructive discussions generated.

CXL is effective in slowing and halting keratoconus and corneal ectasias – but the thinnest corneas can’t receive it, so we propose a new way of bringing CXL to those that need it most

Here, we recognize a year’s worth of innovation. Apps, IOLs, imagers, lasers, devices and drugs – the latest and greatest are all here. But which one came out on top this year?

Glaukos submits iDose IND to the FDA, Allergan bimatoprost implant shows promise, and ALPHAEON makes three deals in as many weeks

Placental growth factor inhibitors might show efficacy in treating dry AMD as well as wet. Might aflibercept be repurposed?

Big data EMR mining (and some basic research) identifies a 50-year old drug that appears to protect against AMD development

Pfizer and Allergan are to combine to form the world’s biggest pharma company, an eyecare behemoth – with a lower tax bill

A new tissue culture model of the retinal pigment epithelium may allow researchers to better understand the impacts of new interventions on the adult human retina